Metraipolis › archive › dc_c7239bdcc6ca

Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformatics and Experimental Study — Europe PMC PMID:42194035

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42194035
DOI: 10.3390/biom16050685
License (as archived): solo-consultazione
Archived: 2026-10-08T14:17:39.484Z
SHA-256 of the archived text: 52d097c714488cca06dd767908135c5f8fba579a2e80593e64a291d5054c6c36
Stable URL of this page: https://metraipolis.com/documento/dc_c7239bdcc6ca

How to cite

Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformatics and Experimental Study — Europe PMC PMID:42194035 — Europe PMC (en), https://europepmc.org/article/MED/42194035 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c7239bdcc6ca (Metraipolis archive dc_c7239bdcc6ca, sha256 52d097c714488cca06dd767908135c5f8fba579a2e80593e64a291d5054c6c36)

BibTeX

@misc{dcc7239bdcc6ca,
  title = {Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformatics and Experimental Study — Europe PMC PMID:42194035},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42194035},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c7239bdcc6ca; sha256 52d097c714488cca06dd767908135c5f8fba579a2e80593e64a291d5054c6c36},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194035. Agents can read the archived copy with the MCP tool read_document.